Healthcare providers adopt imaging AI for concrete clinical reasons: faster answers, more consistent reads, and earlier intervention. The Artificial Intelligence (AI) in Medical Imaging Market was valued at USD 1.89 billion in 2025, according to Polaris Market Research, and is projected to reach USD 28.91 billion by 2034 at a CAGR of 35.3% from 2026 to 2034. The rising prevalence of chronic conditions and the push to improve accuracy while reducing operational costs are central drivers. This article looks at the clinical applications, modalities, and care settings behind the market's expansion.

Chronic Disease and the Case for Early Disease Detection

According to the World Health Organization, noncommunicable diseases account for 74% of global deaths annually. Early detection and precision diagnosis are essential in controlling cancer, cardiovascular disorders, and neurological conditions, and AI-based imaging systems help diagnose anomalies more accurately than traditional systems. The growing requirement for early disease detection is also cited in the report's future outlook as a reason for continued expansion.

Oncology and Breast Cancer Screening

By application, oncology dominated with a 30.90% share in 2025 because of the high prevalence of cancer. AI helps medical professionals detect and recognize tumors at an early stage and identify subtle changes in scans. The report cites an estimated 375 to 450 million CT scans performed worldwide each year. Breast cancer screening holds a significant 20.4% share. According to the WHO, breast cancer is the most common cancer among women globally, with over 2.4 million cases diagnosed annually. AI is integrated into mammography systems to improve detection accuracy, reduce false positives, and help radiologists identify subtle abnormalities, and government initiatives and awareness campaigns further support adoption.

The use-case table in the report points to deployment at scale, noting that Lunit INSIGHT MMG/DBT is deployed at more than 330 sites with over one million annual screenings.

Neurology and Stroke Triage

Neurology is experiencing the highest growth among applications, with a CAGR of 39.4%, driven by the increasing prevalence of disorders such as Alzheimer's disease, stroke, and epilepsy. AI applications in MRI and CT enhance detection and monitoring of brain anomalies, predict disease progression, and assist surgical planning. AI-powered tools are helping providers identify ischemic strokes more accurately and rapidly. The report's use-case table describes stroke triage and care coordination, with products such as Viz.ai and Aidoc, and states that Viz.ai has been deployed in more than 2,000 U.S. hospitals.

For intracerebral hemorrhage patients, Aidoc at Sheba Medical Center showed a 30% reduction in mortality, according to the report's use-case evidence.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/ai-in-medical-imaging-market 

Modalities: CT Scan and Ultrasound Imaging

The CT scan segment held the largest modality share of 32.6% in 2025 owing to its widespread use in diagnosing trauma, cancer, and cardiovascular diseases, and AI is increasingly integrated into CT systems to improve image reconstruction, reduce scan times, and improve diagnostic accuracy. Ultrasound imaging is registering the highest growth, with a CAGR of 38.4%, due to expanding use in obstetrics, cardiology, and point-of-care diagnostics. In March 2026, the FDA approved an ultrasound tool developed by Butterfly Network to detect gestational age. The portability and cost-effectiveness of AI-enabled handheld devices are accelerating adoption in resource-constrained settings and telemedicine.

Care Settings: Hospitals and Diagnostic Imaging Centers

Hospitals dominate by end use with a 48.9% share, reflecting high imaging volumes and advanced infrastructure. Diagnostic imaging centers are experiencing the highest growth at a CAGR of 37.2%, as they adopt AI solutions to improve operational efficiency and offer faster, more accurate diagnostics. Demand for outpatient imaging and the preference for standalone facilities with shorter waiting times are accelerating adoption.

Regional Outlook

North America held 41.2% of the market in 2025, and the U.S. accounted for 59.22% of the regional market. Europe represented 28.6%. Asia Pacific is expected to grow at a CAGR of 38.6%, Latin America at 34.1%, and the Middle East and Africa at 32.8%.

Companies and Recent Developments

Key players include Siemens Healthineers AG, GE HealthCare, Philips Healthcare, Canon Medical Systems Corporation, Aidoc, Lunit, Qure.ai, Viz.ai, HeartFlow, Enlitic, Digital Diagnostics, Vuno, Butterfly Network, Microsoft, NVIDIA Corporation, TEMPUS, Medtronic, Arterys, IBM Watson Health, and Zebra Medical Vision. Recent activity includes GE HealthCare closing its USD 2.3 billion purchase of Intelerad in March 2026, Qure.ai receiving FDA clearance for qXR-Detect in February 2026, and Royal Philips receiving FDA 510(k) clearance for the Philips Spectral CT Verida system in April 2026.

Newer entrants are also active. In August 2026, Perceptra, a Thai-based startup, launched a medical AI system to improve patient screening. Polaris expects the integration of AI with cloud computing, generative AI, and automation to improve diagnosis and imaging and to make operations more efficient, while rising adoption of AI-powered radiology applications by providers should help boost growth.

Conclusion

The Artificial Intelligence (AI) in Medical Imaging Market is being pulled forward by clinical need. Oncology and breast cancer screening anchor current demand, neurology and stroke triage are growing fastest among applications, and ultrasound imaging is widening access at the point of care. As diagnostic imaging centers and hospitals invest in tools that support early disease detection, the market is projected to reach USD 28.91 billion by 2034. Vendors that demonstrate clinical value, regulatory readiness, and smooth integration into radiology workflows will be best positioned to serve this growth.

More Trending Latest Reports By Polaris Market Research:

earphones-and-headphones-market

ai-in-drug-discovery-market

top-5-endobronchial-valve-manufacturers-in-2025

data-center-cooling-market

omega-3-market

glp-drug-market-how-the-obesity-treatment-boom-is-reshaping-global-pharma

alcoholic-beverages-market

contract-research-organization-cro-services-market

biopharma-cold-chain-logistics-market